Achterwehr, Germany

Ernst Kalm

This inventor holds 1 USPTO granted patent. Top assignee: Arexis Ab. Active years: 2008.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ernst Kalm: Innovator in Energy Metabolism Research

Introduction

Ernst Kalm is a notable inventor based in Achterwehr, Germany. He has made significant contributions to the field of energy metabolism through his innovative research and patents. His work focuses on the gamma chain of AMP-activated kinase (AMPK), which plays a crucial role in cellular energy homeostasis.

Latest Patents

Ernst Kalm holds a patent titled "Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof." This patent encompasses variants of the gamma chain of vertebrate AMPK, as well as nucleic acid sequences encoding these variants. The applications of this patent are particularly relevant for the diagnosis and treatment of dysfunctions related to energy metabolism. He has 1 patent to his name.

Career Highlights

Kalm's career has been marked by his dedication to advancing scientific understanding in the field of energy metabolism. His work has implications for various medical conditions, making it a vital area of research. He is currently associated with Arexis AB, a company that focuses on innovative solutions in biotechnology.

Collaborations

Throughout his career, Ernst Kalm has collaborated with talented individuals such as Annie Robic and Denis Milan. These collaborations have enriched his research and contributed to the development of his patented technologies.

Conclusion

Ernst Kalm's contributions to the field of energy metabolism through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatments related to energy metabolism dysfunctions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…